High‐resolution crystal structure of the catalytic domain of human dual‐specificity phosphatase 26. (21st May 2013)
- Record Type:
- Journal Article
- Title:
- High‐resolution crystal structure of the catalytic domain of human dual‐specificity phosphatase 26. (21st May 2013)
- Main Title:
- High‐resolution crystal structure of the catalytic domain of human dual‐specificity phosphatase 26
- Authors:
- Won, Eun‐Young
Xie, Yong
Takemoto, Chie
Chen, Lirong
Liu, Zhi‐Jie
Wang, Bi‐Cheng
Lee, Daeyoup
Woo, Eui‐Jeon
Park, Sung Goo
Shirouzu, Mikako
Yokoyama, Shigeyuki
Kim, Seung Jun
Chi, Seung‐Wook - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Dual‐specificity phosphatases (DUSPs) play an important role in regulating cellular signalling pathways governing cell growth, differentiation and apoptosis. Human DUSP26 inhibits the apoptosis of cancer cells by dephosphorylating substrates such as p38 and p53. High‐resolution crystal structures of the DUSP26 catalytic domain (DUSP26‐C) and its C152S mutant [DUSP26‐C (C152S)] have been determined at 1.67 and 2.20 Å resolution, respectively. The structure of DUSP26‐C showed a novel type of domain‐swapped dimer formed by extensive crossover of the C‐terminal α7 helix. Taken together with the results of a phosphatase‐activity assay, structural comparison with other DUSPs revealed that DUSP26‐C adopts a catalytically inactive conformation of the protein tyrosine phosphate‐binding loop which significantly deviates from that of canonical DUSP structures. In particular, a noticeable difference exists between DUSP26‐C and the active forms of other DUSPs at the hinge region of a swapped C‐terminal domain. Additionally, two significant gaps were identified between the catalytic core and its surrounding loops in DUSP26‐C, which can be exploited as additional binding sites for allosteric enzyme regulation. The high‐resolution structure of DUSP26‐C may thus provide structural insights into the rational design of DUSP26‐targeted anticancer drugs.</p> </abstract>
- Is Part Of:
- Acta crystallographica. Volume 69:Part 6(2013:Jun.)
- Journal:
- Acta crystallographica
- Issue:
- Volume 69:Part 6(2013:Jun.)
- Issue Display:
- Volume 69, Issue 6, Part 6 (2013)
- Year:
- 2013
- Volume:
- 69
- Issue:
- 6
- Part:
- 6
- Issue Sort Value:
- 2013-0069-0006-0006
- Page Start:
- 1160
- Page End:
- 1170
- Publication Date:
- 2013-05-21
- Subjects:
- Biomolecules -- Structure -- Periodicals
Physical biochemistry -- Periodicals
X-ray crystallography -- Periodicals
Crystallography -- Periodicals
572 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://www.blackwell-synergy.com/loi/ayd ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=ayd ↗
http://www.iucr.ac.uk/journals/acta/actad.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1107/S0907444913004770 ↗
- Languages:
- English
- ISSNs:
- 0907-4449
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0612.022000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3352.xml